We are live on
!
Find out more
ED
Exane Derivatives Portfolio holdings
AUM
$174M
1-Year Est. Return
7.84%
This Fund
S&P 500
This Quarter
Est. Return
+25.89%
1 Year Est. Return
-7.84%
3 Year Est. Return
+42.72%
5 Year Est. Return
+56.28%
10 Year Est. Return
–
AUM
$374M
AUM Growth
+$16.3M
(+4.5%)
Cap. Flow
-$27.4M
Cap. Flow
% of AUM
-7.31%
Top 10 Holdings %
Top 10 Hldgs %
27.08%
Holding
761
New
59
Increased
126
Reduced
253
Closed
72
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI China ETF
MCHI
|
+$10.6M |
| 2 |
iShares MSCI South Africa ETF
EZA
|
+$7.66M |
| 3 |
iShares MSCI Malaysia ETF
EWM
|
+$6.49M |
| 4 |
UBS Group
UBS
|
+$5.93M |
| 5 |
Linde
LIN
|
+$5.76M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
RSX
VanEck Russia ETF
RSX
|
+$10.6M |
| 2 |
iShares MSCI Turkey ETF
TUR
|
+$10.5M |
| 3 |
VanEck Gold Miners ETF
GDX
|
+$9.79M |
| 4 |
iShares MSCI Poland ETF
EPOL
|
+$8.27M |
| 5 |
Merck
MRK
|
+$3.11M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 34.4% |
| 2 | Technology | 12.96% |
| 3 | Financials | 11.29% |
| 4 | Healthcare | 10.46% |
| 5 | Consumer Discretionary | 8.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
Edwards Lifesciences
EW
$49.4B
| $372K | 0.1% |
5,388
+5,382
| +89,700% | +$382K |
|
|
PCN
177
PIMCO Corporate & Income Strategy Fund
PCN
$849M
| $367K | 0.1% |
23,200
-16,800
| -42% | -$253K |
|
178
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$14.2B
| $364K | 0.1% |
3,329
-453
| -12% | -$46.9K |
|
|
BRFS
179
DELISTED
BRF SA
BRFS
| $349K | 0.09% |
87,815
-120,655
| -58% | -$465K |
|
180
Energy Fuels
UUUU
$3.14B
| $344K | 0.09% |
230,815
-232,000
| -50% | -$369K |
|
181
PUT
Ferrari
RACE
$71.5B
| $336K | 0.09% |
372
-7
| -2% | -$1.13K |
|
|
182
CALL
Ferrari
RACE
$71.5B
| $334K | 0.09% |
144
-17
| -11% | -$2.74K |
|
183
Pfizer
PFE
$157B
| $328K | 0.09% |
10,582
-3,074
| -23% | -$104K |
|
184
WisdomTree India Earnings Fund ETF
EPI
$1.95B
| $325K | 0.09% |
16,225
-1,404
| -8% | -$25.6K |
|
185
Enbridge
ENB
$106B
| $318K | 0.08% |
10,534
| – | – |
|
186
Viking Therapeutics
VKTX
$3.49B
| $316K | 0.08% |
43,873
-9,301
| -17% | -$61.8K |
|
|
PPLT
187
abrdn Physical Platinum Shares ETF
PPLT
$2.17B
| $306K | 0.08% |
39,110
+21,660
| +124% | +$162K |
|
188
iShares TIPS Bond ETF
TIP
$14.7B
| $297K | 0.08% |
2,415
-352
| -13% | -$42.8K |
|
189
Coca-Cola
KO
$382B
| $297K | 0.08% |
6,644
+795
| +14% | +$36.6K |
|
190
Abbott
ABT
$177B
| $288K | 0.08% |
3,152
+2,202
| +232% | +$199K |
|
191
Bilibili
BILI
$6.37B
| $288K | 0.08% |
+6,219
| New | +$202K |
|
192
Baxter International
BAX
$12.3B
| $287K | 0.08% |
3,332
+3,323
| +36,922% | +$289K |
|
193
TG Therapeutics
TGTX
$8.12B
| $284K | 0.08% |
14,580
-3,858
| -21% | -$62.1K |
|
194
Global X Cloud Computing ETF
CLOU
$365M
| $278K | 0.07% |
+13,000
| New | +$239K |
|
195
Global X Lithium & Battery Tech ETF
LIT
$1.47B
| $277K | 0.07% |
8,744
+8,700
| +19,773% | +$234K |
|
196
Invesco Dorsey Wright Healthcare Momentum ETF
PTH
$284M
| $276K | 0.07% |
6,777
+699
| +12% | +$24.8K |
|
197
Trip.com Group
TCOM
$24.7B
| $273K | 0.07% |
+10,538
| New | +$266K |
|
198
iShares Global Healthcare ETF
IXJ
$4.2B
| $270K | 0.07% |
3,926
-2,707
| -41% | -$183K |
|
199
Eldorado Gold
EGO
$10.5B
| $263K | 0.07% |
27,105
-48,245
| -64% | -$419K |
|
200
Healthpeak Properties
DOC
$13.9B
| $259K | 0.07% |
9,408
+3,829
| +69% | +$97.7K |
|
Similar funds
PC
TWMP
LPWM
ACM
HWIS
LWM
EW
GDWAM
Exane Derivatives's Q2 2020 Portfolio in Review
As of Q2 2020, Exane Derivatives held 761 positions worth $374M, up 4.5% from $358M the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Exane Derivatives withdrew a net $27.4M in Q2 2020, closing 72 positions and reducing 253 holdings. Its most notable exit was iShares MSCI Turkey ETF, an estimated $10.5M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 34% of assets, down from 44% a quarter earlier, followed by Technology and Financials.
Against the trend, Exane Derivatives opened a new position in iShares MSCI South Africa ETF worth $8.2M.
- Exane Derivatives's largest Q2 2020 buy was iShares MSCI South Africa ETF: 232,582 shares worth $8.2M.
- Exane Derivatives added most to iShares MSCI China ETF in Q2 2020, an estimated $10.6M increase.
- Exane Derivatives's biggest Q2 2020 reduction was VanEck Russia ETF, cutting an estimated $10.6M.
- Exane Derivatives fully exited iShares MSCI Turkey ETF in Q2 2020, selling an estimated $10.5M.
- Exane Derivatives's ten largest holdings make up 27% of its $374M portfolio in Q2 2020.
- Exane Derivatives opened 59 new positions and closed 72 in Q2 2020.
- Exane Derivatives's portfolio value rose 4.5% quarter-over-quarter to $374M.
Based on Exane Derivatives's 13F filing for Q2 2020, filed 10 Jul 2020.